The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-6-((S)-2-amino-1-phenylethoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol ID: ALA1099296
PubChem CID: 46886549
Max Phase: Preclinical
Molecular Formula: C23H25N7O3
Molecular Weight: 447.50
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CN)c3ccccc3)cc21
Standard InChI: InChI=1S/C23H25N7O3/c1-4-30-16-12-18(32-17(13-24)14-8-6-5-7-9-14)26-15(10-11-23(2,3)31)19(16)27-22(30)20-21(25)29-33-28-20/h5-9,12,17,31H,4,13,24H2,1-3H3,(H2,25,29)/t17-/m1/s1
Standard InChI Key: VLGIYSJSJHPDHN-QGZVFWFLSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
-3.5967 -18.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0912 -17.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8717 -17.7367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.8543 -18.5627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0632 -18.8000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8507 -16.6773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7719 -18.1052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7961 -18.9319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0797 -18.5185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0825 -17.6880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7979 -17.2789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2928 -18.7685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5109 -18.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5083 -17.6968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2901 -17.4416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3161 -19.5932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0419 -19.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8030 -16.4539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8083 -15.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8125 -14.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1001 -14.3839 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5290 -14.3911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8167 -13.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6355 -18.9299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6367 -19.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3519 -20.1663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3532 -20.9913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0771 -20.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7891 -19.7533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5024 -20.1662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5016 -20.9921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7814 -21.4033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0711 -20.9880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
12 16 1 0
13 8 1 0
16 17 1 0
3 4 1 0
11 18 1 0
8 9 2 0
18 19 3 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
5 1 2 0
20 22 1 0
10 11 2 0
20 23 1 0
11 14 1 0
9 24 1 0
13 14 2 0
24 25 1 0
25 26 1 6
2 6 1 0
26 27 1 0
2 3 2 0
25 28 1 0
1 7 1 0
28 29 2 0
12 13 1 0
29 30 1 0
14 15 1 0
30 31 2 0
15 7 2 0
31 32 1 0
7 12 1 0
32 33 2 0
33 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 447.50Molecular Weight (Monoisotopic): 447.2019AlogP: 2.28#Rotatable Bonds: 6Polar Surface Area: 151.13Molecular Species: BASEHBA: 10HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.26CX Basic pKa: 9.00CX LogP: 2.60CX LogD: 1.00Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: -0.68
References 1. Rouse MB, Seefeld MA, Leber JD, McNulty KC, Sun L, Miller WH, Zhang S, Minthorn EA, Concha NO, Choudhry AE, Schaber MD, Heerding DA.. (2009) Aminofurazans as potent inhibitors of AKT kinase., 19 (5): [PMID:19179070 ] [10.1016/j.bmcl.2009.01.002 ]